GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » XSpray Pharma AB (OSTO:XSPRAY) » Definitions » Float Percentage Of Total Shares Outstanding

XSpray Pharma AB (OSTO:XSPRAY) Float Percentage Of Total Shares Outstanding : 0.00% (As of May. 24, 2025)


View and export this data going back to 2017. Start your Free Trial

What is XSpray Pharma AB Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, XSpray Pharma AB's float shares is 0.00 Mil. XSpray Pharma AB's total shares outstanding is 37.14 Mil. XSpray Pharma AB's float percentage of total shares outstanding is 0.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, XSpray Pharma AB's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, XSpray Pharma AB's Institutional Ownership is 2.28%.

XSpray Pharma AB Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

XSpray Pharma AB's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=0.00/37.14
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

XSpray Pharma AB Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » XSpray Pharma AB (OSTO:XSPRAY) » Definitions » Float Percentage Of Total Shares Outstanding
Comparable Companies
OSTO:EGTX OSTO:GENO OSTO:SANION OSTO:SYNACT OSTO:VICO OSTO:DMYD B XSAT:HAMLET B OSTO:HNSA OSTO:IBT B OSTO:BINV VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
0GHZ:UK
Address
Scheeles vag 2, Solna, SWE, SE-171 65
Website
https://www.xspraypharma.com
XSpray Pharma AB is a pharmaceutical company focused on developing improved PKIs for cancer treatment, leveraging its proprietary HyNap technology platform. The company aims to enhance clinical outcomes for cancer patients by improving the efficacy, safety, and patient experience of existing cancer therapies. Its product portfolio includes Dasynoc and other product candidates in different stages of development such as XS003 nilotinib, XS008 axitinib, and other.

XSpray Pharma AB Headlines

No Headlines